Hui Liu - 13 May 2025 Form 4 Insider Report for Rallybio Corp (RLYB)

Reporting relationship: Director
Issuer ticker: RLYB
Reported as of: 13 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2025, 17:03:44 UTC
Prior SEC filing: 06 Jan 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Michael Greco, Attorney-in-Fact

Key filing fact

Hui Liu filed Form 4 for Rallybio Corp (RLYB) on 15 May 2025.

Key facts

This page summarizes Hui Liu's Form 4 filing for Rallybio Corp (RLYB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 May 2025, 17:03.

Change

Previous filing in this sequence was filed on 06 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001790518 Primary reporting owner

Liu Hui

Relationship: Director
Address: C/O RALLYBIO CORPORATION, 234 CHURCH STREET, SUITE 1020, NEW HAVEN
Signature: By: /s/ Michael Greco, Attorney-in-Fact
Signature date: 15 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RLYB transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +28,500
Change %
Price: $0.000000
Shares after: 28,500
Date: 13 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,500
Exercise price: $0.3000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders.